Trial intelligence / Profile preview

Lacosamide adjunctive therapy in infants and young children with focal seizures

MOH_2017-03-09_000221Phase 3Recruiting

Sponsor
UCB
Start
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Focal Onset Epilepsy comparing Lacosamide oral syrup with Matching placebo syrup (2 arms). Primary endpoint: Not reported. Started Mar 2015; status: recruiting.

02

Drugs

lacosamide
03

Conditions

Focal Onset Epilepsy

Beyond the preview

Go deeper on MOH_2017-03-09_000221.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on MOH_2017-03-09_000221.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call